Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment

BACKGROUND: Parkinson's disease (PD) is a disease of ⍺-synuclein aggregation-mediated dopaminergic neuronal loss in the substantia nigra pars compacta, which leads to motor and non-motor symptoms. Through the last two decades of research, there has been growing consensus that inflammation-media...

Descripción completa

Detalles Bibliográficos
Autores principales: Salim, Safa, Ahmad, Fatima, Banu, Ayesha, Mohammad, Farhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403695/
https://www.ncbi.nlm.nih.gov/pubmed/36332796
http://dx.doi.org/10.1016/j.jare.2022.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403695/
https://www.ncbi.nlm.nih.gov/pubmed/36332796
http://dx.doi.org/10.1016/j.jare.2022.10.013

Ejemplares similares